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Genetic testing: a difference from the reference 
genome (variant) may indicate disease. 
Incidental finding: variant in gene unrelated to 
diagnostic indication that prompted sequencing.
-Due to multiple testing and low priors, these 
typically have high rates of false positives, 
so we normally don’t report them. 
ACMG (American College of Medical Genetics 
& Genomics): recommends an exception for 56 
genes thought to be more indicative of disease.
1000 Genomes Project: contains whole-genome 
sequence data for 2,504 healthy adults from 
diverse ethnic populations.
ExAC: aggregates population-level data from 
60,706 diverse human whole-genome sequences. 
ClinVar: central repository of interpretations for 
genetic variants (benign vs. pathogenic).
INTRODUCTION
(Genetic	Testing	and	Relevant	Datasets)
OBJECTIVES
𝑃𝑒𝑛𝑒𝑡𝑟𝑎𝑛𝑐𝑒 = 𝑃 𝐷 𝑉 = 𝑃 𝐷 ∗ 𝑃(𝑉|𝐷)𝑃 𝑉 = 𝑝𝑟𝑒𝑣𝑎𝑙𝑒𝑛𝑐𝑒 𝑎𝑙𝑙𝑒𝑙𝑖𝑐	ℎ𝑒𝑡𝑒𝑟𝑜𝑔𝑒𝑛𝑒𝑖𝑡𝑦(𝑎𝑙𝑙𝑒𝑙𝑒	𝑓𝑟𝑒𝑞𝑢𝑒𝑛𝑐𝑦)
where D = disease, V = any variant
PENETRANCE	MODEL
KEY	FIGURES
CONCLUSIONS
1. High counts: 40-80% of individuals have 
an incidental finding under ACMG guidelines, 
far higher than empirical disease prevalences. 
2. Clustered distribution: by ethnicity –
AFR (African) have the most findings, 
EAS (East Asian) have the fewest.
3. High sensitivity: findings dominated 
by a few high-frequency variants. 
4. Very low penetrance estimates:
Out of the 30 diseases (22 with data): 
(a) 20 have max theoretical penetrance < 50% 
(b) 12 have max theoretical penetrance < 5%
5. High uncertainty around parameters:
translates into very large errors bars. 
-This is a preliminary “letter-of-the-law” 
evaluation and does not yet demonstrate 
real-world effects on patients. 
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1. Develop an ETL workflow for extraction, 
transformation, and loading of genomic and 
interpretation data from relevant sources. 
2. Evaluate variant distribution across a 
healthy, diverse cohort (1000 Genomes). 
3. Estimate plausible penetrance ranges 
for the ACMG recommendations.
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Penetrance	Estimates	for	Incidental	Genomic	Findings
NEXT	STEPS
1. Identify questionable variants:
(a) high-frequency (common findings)
(b) highly enriched in 1 ethnic population. 
2. Validation with empirical penetrance values 
and other sequencing datasets (e.g. gnomAD). 
3. Model biases in parameter estimates 
(prevalence, pathogenicity, etc.) 
4. Confer with clinical collaborators 
to determine alternate protocols at Laboratory of 
Molecular Medicine and Partners HealthCare. 
METHODS	&	WORKFLOW
Penetrance: Probability of developing disease, given a positive genetic test result. 
Prevalence: Proportion of general population with disease.
Allelic Heterogeneity:    Proportion of diseased population with a pathogenic variant.
Allele Frequency: Proportion of general population with a pathogenic variant. 
https://github.com/jamesdiao/2016-paper-ACMG-penetrance
ETL for Datasets
Pipeline + UI using R/Shiny/Markdown
1. Extract: query UCSC Genome Browser for 
gene regions and retrieve corresponding VCF 
files from 1000 Genomes. Download ExAC 
manually from gene-level searches. 
2. Transform: separate variants with multiple 
alternates; convert genotypes to allele counts, 
collect missense variants.
3. Load: Stage and merge final data objects. 
Heatmap + Barplot: Penetrance Estimates are Low and Variable between Ancestral Groups
